首页|万古霉素新旧AUC0-24/MIC计算模型的一致性评价及临床疗效预测价值比较

万古霉素新旧AUC0-24/MIC计算模型的一致性评价及临床疗效预测价值比较

扫码查看
目的:比较万古霉素新(新近文献建立)、旧(既往文献建立)两种AUC0-24/MIC(24h药时曲线下面积与最低抑菌浓度比值)模型计算AUC0-24/MIC值的一致性及对临床疗效的预测价值。方法:回顾性分析42例血流感染患者的临床资料,收集5种共42株耐甲氧西林葡萄球菌,采用配对样本t检验和Bland-Altman图考察所有患者共65种方案基于两模型的65对AUC0-24/MIC值的差异。采用Spearman等级相关分析考察并比较42例患者所有方案共97对基于模型预测的理论疗效分级与实际疗效分级的相关性,以评价两模型的临床疗效预测价值。采用相关系数考察共42对基于两模型的AUC0-24/MIC值与万古霉素用药前后血清肌酐变化情况的相关性,以评价两模型对万古霉素肾毒性的预测价值。结果:两模型AUC0-24/MIC值差异显著,新模型较旧模型平均高28。9,最高62。2。基于新模型的日剂量较旧模型平均高78~1 198 mg。基于两模型的理论疗效分级与实际疗效分级均显著相关,但新模型相关性更高(Speaman等级相关系数新模型vs。旧模型为0。826vs。0。656)。两模型AUC0-24/MIC值与血清肌酐变化均无显著相关。结论:两种AUC0-24/MIC模型不具有一致性,新模型具有更高的临床疗效预测价值,两模型均无法预测万古霉素的肾毒性。
Evaluating the consistency of the new and old calculation models of AUC0-24/MIC for vancomycin and com-paring their prediction values on clinical efficacy
OBJECTIVE To evaluate the predictive value of the old(previously developed)and new(recently established)AUC0-24/MIC(ratio of daily area under concentration-time curve to minimal inhibitory concentration)models for vancomycin in terms of clinical efficacy.METHODS The relevant clinical data were retrospectively reviewed for 42 patients with bloodstream infections.A total of 42 strains of methicillin-resistant staphylococci were detected from 5 species.Regarding the differences between two models,65 pairs of AUC0-24/MIC values from 65 regimens were acquired with paired sample t-test and Bland-Altman plot.As for the predictability of two models on clinical efficacy,Spearman's rank correlation analysis was utilized for com-paring the correlation between 97 pairs of model-based efficacy grading and actual efficacy grading in all regimens at various treat-ment stages.Regarding the prediction of models for vancomycin nephrotoxicity,correlation coefficients were utilized for examin-ing the correlation between 42 pairs of model-based AUC0-24/MIC values and altered serum creatinine levels before and after treat-ment.RESULTS The values of AUC0-24/MIC by two models differed greatly.AUC0-24/MIC calculated by novel model was on average 28.9 greater than that predicted by old model with a maximum of 62.2 h.Daily dose calculated by novel model was at least 78 mg higher on average and as high as 1 198 mg higher than that calculated by the previous model.Actual efficacy grading and theoretical efficacy grading predicted by two models were markedly correlated.However,the novel model showed a stronger connection(Spearman grade correlation coefficient for the novel model and the old model was 0.826 vs.0.656).No discernible relationship existed between altered serum creatinine levels and model-based AUC0-24/MIC values.CONCLUSION Two mod-els areinconsistent for calculating the AUC0-24/MIC values of vancomycin.This novel model has better predictive value for clinical efficacy.Nevertheless,neither model can forecast vancomycin's nephrotoxicity.

vancomycinevaluation modelconsistency evaluationclinical efficacyprediction values

郑春茂、欧玮、宋香清

展开 >

郴州市第一人民医院药学部,湖南郴州 423000

岳阳市中心医院药剂科,湖南岳阳 414000

湖南省肿瘤医院药学部,湖南长沙 410013

万古霉素 评价模型 一致性评价 临床疗效 预测价值

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(9)
  • 34